Galen JE - Search Results

1

Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Orr N, Galen JE, Levine MM. Orr N, et al. Among authors: galen je. Infect Immun. 1999 Aug;67(8):4290-4. doi: 10.1128/IAI.67.8.4290-4294.1999. Infect Immun. 1999. PMID: 10417208 Free PMC article.

2

Role of Vibrio cholerae neuraminidase in the function of cholera toxin.

Galen JE, Ketley JM, Fasano A, Richardson SH, Wasserman SS, Kaper JB. Galen JE, et al. Infect Immun. 1992 Feb;60(2):406-15. doi: 10.1128/iai.60.2.406-415.1992. Infect Immun. 1992. PMID: 1730470 Free PMC article.

3

Construction of genetically marked Vibrio cholerae O1 vaccine strains.

Ketley JM, Michalski J, Galen J, Levine MM, Kaper JB. Ketley JM, et al. FEMS Microbiol Lett. 1993 Jul 15;111(1):15-21. doi: 10.1111/j.1574-6968.1993.tb06355.x. FEMS Microbiol Lett. 1993. PMID: 8359676

4

CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.

Michalski J, Galen JE, Fasano A, Kaper JB. Michalski J, et al. Among authors: galen je. Infect Immun. 1993 Oct;61(10):4462-8. doi: 10.1128/iai.61.10.4462-4468.1993. Infect Immun. 1993. PMID: 8406837 Free PMC article.

5

Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.

Gómez-Duarte OG, Galen J, Chatfield SN, Rappuoli R, Eidels L, Levine MM. Gómez-Duarte OG, et al. Vaccine. 1995 Nov;13(16):1596-602. doi: 10.1016/0264-410x(95)00094-h. Vaccine. 1995. PMID: 8578848

6

Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.

Levine MM, Galen J, Barry E, Noriega F, Chatfield S, Sztein M, Dougan G, Tacket C. Levine MM, et al. J Biotechnol. 1996 Jan 26;44(1-3):193-6. doi: 10.1016/0168-1656(95)00094-1. J Biotechnol. 1996. PMID: 8717403 Review.

7

Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.

Barry EM, Gomez-Duarte O, Chatfield S, Rappuoli R, Pizza M, Losonsky G, Galen J, Levine MM. Barry EM, et al. Infect Immun. 1996 Oct;64(10):4172-81. doi: 10.1128/iai.64.10.4172-4181.1996. Infect Immun. 1996. PMID: 8926085 Free PMC article.

8

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

Galen JE, Gomez-Duarte OG, Losonsky GA, Halpern JL, Lauderbaugh CS, Kaintuck S, Reymann MK, Levine MM. Galen JE, et al. Vaccine. 1997 Apr-May;15(6-7):700-8. doi: 10.1016/s0264-410x(96)00227-7. Vaccine. 1997. PMID: 9178472

9

Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.

Levine MM, Galen J, Barry E, Noriega F, Tacket C, Sztein M, Chatfield S, Dougan G, Losonsky G, Kotloff K. Levine MM, et al. Behring Inst Mitt. 1997 Feb;(98):120-3. Behring Inst Mitt. 1997. PMID: 9382732 Review. No abstract available.

10

Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.

Galen JE, Nair J, Wang JY, Wasserman SS, Tanner MK, Sztein MB, Levine MM. Galen JE, et al. Infect Immun. 1999 Dec;67(12):6424-33. doi: 10.1128/IAI.67.12.6424-6433.1999. Infect Immun. 1999. PMID: 10569759 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters